The findings were published in Nature Communications. HIV is a virus that attacks cells in the body fighting off infections, thus weakening the immune system. Antiretroviral therapies can treat ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Human immunodeficiency virus, more commonly referred to as HIV, is a virus that attacks cells that help the body fight ...

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...

In the case of HIV, EBC-46 activates infected cells, exposing the virus and allowing our antibodies to attack them. “We want safe and effective ways to flush out latent virus,” Marsden says. In the ...

Antiretroviral therapy (ART) can keep HIV suppressed indefinitely, but the virus inserts its genetic blueprints into ... Afterwards, he developed near-fatal GVHD, which occurs when donor immune cells ...

INSTIs block integrase, an enzyme that HIV uses to put HIV DNA into human DNA inside the CD4 T cells. INSTIs belong ... stop working for them, and the virus could start multiplying.

This thesis explores how these memory T cells work in different viral infections, with a focus on Epstein-Barr virus (EBV), Human Immunodeficiency virus (HIV) and SARS-CoV-2 virus. First ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used ... the replication of the chikungunya virus. In cell lines, the HIV/AIDS drug efavirenz ...